Stocks and Investing Stocks and Investing
Mon, August 12, 2024

Andrew Fein Reiterated (ZNTL) at Strong Buy and Held Target at $20 on, Aug 12th, 2024


Published on 2024-10-28 13:33:52 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Reiterated "Zentalis Pharmaceuticals, Inc." (ZNTL) at Strong Buy and Held Target at $20 on, Aug 12th, 2024.

Andrew has made no other calls on ZNTL in the last 4 months.



There are 5 other peers that have a rating on ZNTL. Out of the 5 peers that are also analyzing ZNTL, 3 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Eliana Merle of "UBS" Downgraded from Strong Buy to Hold and Decreased Target to $5 on, Thursday, June 20th, 2024
  • Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $8 on, Tuesday, June 18th, 2024
  • Derek Archila of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $9 on, Tuesday, June 18th, 2024


These are the ratings of the 2 analyists that currently disagree with Andrew


  • Matthew Biegler of "Oppenheimer" Maintained at Buy with Decreased Target to $25 on, Tuesday, June 18th, 2024
  • Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $10 on, Tuesday, June 18th, 2024
Contributing Sources